Mitochondrial α-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo.
Alpha-synuclein is the major protein component of Lewy bodies, a cardinal pathological feature of the degenerating Parkinsonian brain. Alpha-synuclein has been reported to be able to intercalate into membranes via formation of an alpha-helical structure at its N-terminal end. Recent in vitro studies from various laboratories have demonstrated that α-synuclein can physically associate with mitochondria and interfere with mitochondrial function. α-Syn predominantly associates with the inner mitochondrial membrane, where it can apparently interact with complex I resulting in reduced mitochondrial complex I activity and increased free radical production. However, the effect of in vivo α-synuclein accumulation within dopaminergic neurons on mitochondrial function has not been thoroughly studied. Examination of transgenic animals which overexpress the familial mutant A53T form of the protein selectively within dopaminergic neurons reveals that A53T localizes to the mitochondrial membranes as monomers and oligomers particularly under conditions of proteasomal inhibitory stress, and that this localization coincides with a selective age-related mitochondrial complex I inhibition and decreased substrate-specific respiration along with increases in mitochondrial autophagy (mitophagy).
Chinta
Shankar J
SJ
Buck Institute for Age Research, Novato, CA 94945, United States.
Mallajosyula
Jyothi K
JK
Rane
Anand
A
Andersen
Julie K
JK
D000375:Aging / Q000235:genetics / Q000378:metabolism; D000818:Animals; D001343:Autophagy / Q000235:genetics*; D004195:Disease Models, Animal; D004298:Dopamine / Q000502:physiology; D042967:Electron Transport Complex I / Q000037:antagonists & inhibitors* / Q000235:genetics* / Q000502:physiology; D051379:Mice; D008822:Mice, Transgenic; D051336:Mitochondrial Membranes / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology*; D009474:Neurons / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology; D010300:Parkinson Disease / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D046988:Proteasome Endopeptidase Complex / Q000235:genetics; D061988:Proteasome Inhibitors; D013378:Substantia Nigra / Q000201:enzymology / Q000378:metabolism / Q000473:pathology; D051844:alpha-Synuclein / Q000235:genetics / Q000378:metabolism*
D061988:Proteasome Inhibitors; D051844:alpha-Synuclein; D046988:Proteasome Endopeptidase Complex; D042967:Electron Transport Complex I; D004298:Dopamine